Greater Cannabis Company (GCAN) Total Debt Growth (3y) (2019 - 2023)
Greater Cannabis Company (GCAN) Total Debt Growth (3y) (2019 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -2.21% |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -7.03% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 63.29% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 1,183.78% |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -7.76% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -14.15% |
| 10 | Greater Cannabis Company | 292,929.85 | 292,929.85 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -60.20% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 14.96% |
| Jun 30, 2022 | 3.11% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 29.99% |
| Jun 30, 2021 | 144.62% |
| Mar 31, 2021 | 184.68% |
| Dec 31, 2020 | 289.52% |
| Sep 30, 2020 | 408.04% |
| Dec 31, 2019 | 428.53% |